What is Elanco Animal Health Inc.'s accrued litigation?

Elanco Animal Health Inc. (ELAN) reported accrued litigation of $0 in Q1 2026.

Elanco Animal Health Inc. ELAN Accrued Litigation

Accrued Litigation at other companies

MastercardMA

-$461M-487%

Altria GroupMO

$659M-2.8%

McKessonMCK

-$15M0.0%

Altria GroupMO

$2.84B-6.4%

Krystal Biotech, Inc.KRYS

$0+100%

Carnival CorporationCCL

$4M—

Other financials

Income statement

See full

Revenue$1.4B+14.9%

Gross profit$785.0M+14.8%

Net income$57.0M-14.9%

EPS (diluted)$0.11-15.4%

Balance sheet

See full

Cash & equivalents$428.0M-12.1%

Total debt$4.3B-1.7%

Total equity$6.5B+2.3%

Total assets$13.2B+2.2%

Cash flow

See full

Operating cash flow$13.0M+425%

CapEx$51.0M-21.5%

Free cash flow-$38.0M+44.9%

Valuation

See full

Market cap$12.1B+128%

Enterprise value$15.99B+73.1%

P/S2.5×+1.3×

Profitability

See full

Gross margin55.1%+0.2pp

Net margin-4.9%-13.6pp

FCF margin6.4%-1.4pp

Returns & leverage

See full

Return on equity-3.8%-9.9pp

Debt / equity0.7×0.0×

Current ratio2.2×-0.6×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:LitigationReserve.

The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elanco Animal Health Inc.'s accrued litigation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Elanco Animal Health Inc.'s accrued litigation?: Elanco Animal Health Inc. (ELAN) reported accrued litigation of $0 in Q1 2026.